Company Overview and News
Listing and trading of the under mentioned security has been cancelled with effect from 27th June 2017.
Strides Shasun will use the funding from KKR to restructure existing loans as well as expand some of the businesses
Claris Lifesciences has a total of 40 abbreviated new drug applications filed with the US FDA, of which 16 have been approved
Shares of Mylan, Inc. (MYL - Free Report) declined 2% after the company received a warning letter from the FDA for its manufacturing facility in India.
Newgen Software Inc., a leading global provider of Business Process Management (BPM), Enterprise Content Management (ECM), Customer Communication Management (CCM) and Case Management solutions, announced that it has been positioned as a 'Leader' in The Forrester Wave™: ECM Transactional Content Services, Q2 2017, authored by Cheryl McKinnon with Alex Cullen, Alex Kramer, and Sam Bartlett.
HERTFORDSHIRE, England and PITTSBURGH, March 1, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results for the quarter and year ended December 31, 2016 and provided 2017 guidance.
Sun Pharma | Maruti Suzuki | Redington | Sasken Communications | Voltamp Transformers | Strides Arcolab | JK Paper | Edelweiss Financial | Tata Metaliks | Hinduja Ventures | Suzlon Energy | Mahindra & Mahindra Financial and Hinduja Ventures are stocks, which are in the news today.
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission
HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results for the quarter and nine months ended September 30, 2016.
Pharma major Strides Shasun and the US-based Mylan have agreed to settle regulatory and general claims on Agila transaction.
Strides had completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to USD 1.75 billion in December 2013.
As per the settlement, Strides will get about $30 million from regulatory escrow after it makes the payment to Mylan on acquisition of injectables unit Agila Specialties
Strides Arcolab Ltd's Q2FY17 consolidated net profit rises 106.73% yoy to Rs.74.1 crore : In-line with Estimates
CDSCO plans to rope in state drug control organizations to look into the issues raised by Vietnam over the quality of drugs from India
Strides Shasun gained 0.98% to Rs 966.95 at 14:25 IST on BSE after the company announced that it has received approval from the United States Food & Drug Administration for Ranitidine Tablets.
"Oral dosage forms manufacturing site in Bangalore has received the establishment inspection report (EIR) from the US Food & Drug Administration, thereby confirming the closure of the inspection. The facility continues to be US FDA Approved," the pharma company said in its filing.
9.55 am: There will lots of important earnings announcements too, to keep the markets in action. Strides Arcolab, Shasun, JK Tyre, Petronet LNG, NBCC, TRF, Mangalam Cement, Tata Coffee, BF Utilities and Gujarat Fluorochemicals, among others are scheduled to announce their results today.
I like the idea of letting money work for me on its own. One way to do that is buying equities that generate dividends. Last year, about 10% of our gains were from dividends, capital gains, and intere
Results from a Phase 3 clinical trial, C-EDGE CO-STAR, show a 95% (n=189/198) cure rate in HCV-1, -4 or -6-positive patients who inject drugs and are receiving opioid agonist therapy for their ad
Merck , known as MSD outside the United States and Canada, today announced the presentation of results from the company’s Phase 3 C-EDGE CO-STAR clinical trial evaluating the efficacy and safety of the investigational once-daily tablet elbasvir/grazoprevir1 in patients with chronic hepatitis C virus genotypes 1, 4 or 6 infection who inject drugs and are receiving opioid agonist therapy .
The typical millennial profile (post-college graduation) has human capital as their only asset, but is also effectively short both bonds (student debt) and residential real estate (renters).Given most
The faster pace of buybacks for iStar Financial (NYSE:STAR) is especially notable given CEO Jay Sugarman earlier this year was dismissive of the notion that repurchases represented the company's best
The buyback program had $28.5M of remaining availability as of June 30, and recent purchases have brought that amount down to about $10M. The board authorizes an increase to $50M.At today's close of $
The multi-billion dollar redevelopment plan for a 1.25 mile stretch of Asbury Park waterfront involves more than 20 individual projects, and iStar (NYSE:STAR) CEO Jay Sugarman has assembled an "al
Why the gap between iStar's (STAR -0.7%) asset value/business prospects and the share price? First, says Mark Palmer, is the stock doesn't fit neatly into a single coverage category, i.e. it's a REIT
13h - Asif